Yee Soo Chae

7.2k total citations
172 papers, 3.0k citations indexed

About

Yee Soo Chae is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Yee Soo Chae has authored 172 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Oncology, 66 papers in Cancer Research and 54 papers in Pathology and Forensic Medicine. Recurrent topics in Yee Soo Chae's work include Breast Cancer Treatment Studies (34 papers), Lymphoma Diagnosis and Treatment (26 papers) and Breast Lesions and Carcinomas (17 papers). Yee Soo Chae is often cited by papers focused on Breast Cancer Treatment Studies (34 papers), Lymphoma Diagnosis and Treatment (26 papers) and Breast Lesions and Carcinomas (17 papers). Yee Soo Chae collaborates with scholars based in South Korea, United States and Japan. Yee Soo Chae's co-authors include Soo Jung Lee, Jong Gwang Kim, Ho Yong Park, Jin Hyang Jung, Gyu‐Seog Choi, Joon Ho Moon, Byung Woog Kang, Sang Kyun Sohn, Jeeyeon Lee and Wan Wook Kim and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yee Soo Chae

162 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yee Soo Chae South Korea	30	1.3k	1.0k	911	866	413	172	3.0k
Cristovam Scapulatempo‐Neto Brazil	31	1.3k 1.0×	988 1.0×	1.1k 1.2×	413 0.5×	598 1.4×	162	3.2k
Gerold Meinhardt United States	27	1.0k 0.8×	1.0k 1.0×	1.3k 1.4×	1.2k 1.4×	725 1.8×	58	4.8k
Jae Hong Seo South Korea	27	859 0.7×	818 0.8×	1.6k 1.8×	260 0.3×	523 1.3×	142	3.1k
Alan B. Tuck Canada	39	2.1k 1.6×	1.1k 1.0×	1.5k 1.7×	448 0.5×	317 0.8×	74	4.2k
Hannelore Denys Belgium	28	1.1k 0.9×	734 0.7×	1.3k 1.4×	200 0.2×	358 0.9×	148	3.1k
Lainie P. Martin United States	29	1.2k 0.9×	366 0.4×	1.7k 1.8×	469 0.5×	414 1.0×	100	3.2k
Morten Mau‐Sørensen Denmark	28	1.1k 0.9×	541 0.5×	1.2k 1.3×	310 0.4×	527 1.3×	130	2.7k
Paul Frankel United States	34	1.8k 1.4×	658 0.6×	1.9k 2.1×	337 0.4×	967 2.3×	214	4.1k
Gilbert Spizzo Austria	29	2.1k 1.6×	723 0.7×	1.7k 1.9×	244 0.3×	488 1.2×	70	3.8k
Toshiaki Saeki Japan	32	1.2k 0.9×	600 0.6×	1.7k 1.8×	254 0.3×	476 1.2×	170	3.1k

Countries citing papers authored by Yee Soo Chae

Since Specialization

Citations

This map shows the geographic impact of Yee Soo Chae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yee Soo Chae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yee Soo Chae more than expected).

Fields of papers citing papers by Yee Soo Chae

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yee Soo Chae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yee Soo Chae. The network helps show where Yee Soo Chae may publish in the future.

Co-authorship network of co-authors of Yee Soo Chae

This figure shows the co-authorship network connecting the top 25 collaborators of Yee Soo Chae. A scholar is included among the top collaborators of Yee Soo Chae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yee Soo Chae. Yee Soo Chae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamashita, Toshinari, Joohyuk Sohn, Eriko Tokunaga, et al.. (2024). Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study. Breast Cancer. 31(5). 858–868. 6 indexed citations

Pivot, Xavier, Javier Cortés, Diana Lüftner, et al.. (2023). Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer. JAMA Network Open. 6(4). e235822–e235822. 7 indexed citations

Lee, Jeeyeon, Ho Yong Park, Wan Wook Kim, et al.. (2021). Value of accurate diagnosis for metastatic supraclavicular lymph nodes in breast cancer: assessment with neck US, CT, and 18F-FDG PET/CT. Diagnostic and Interventional Radiology. 27(3). 323–328. 2 indexed citations

Park, Ho Yong, Wan Wook Kim, Chan Sub Park, et al.. (2020). Clinical efficacy of intraoperative ultrasound for margin assessment in breast‐conserving surgery. The Breast Journal. 26(11). 2308–2311.

Baek, Dong Won, Ji Young Park, Soo Jung Lee, & Yee Soo Chae. (2020). The Therapeutic Effect of Cyclin-Dependent Kinase 4/6 Inhibitor on Relapsed Ectopic Male Breast Cancer. Journal of Breast Cancer. 23(5). 560–560.

Baek, Dong Won, Soo Jung Lee, Sang Kyun Sohn, Joon Ho Moon, & Yee Soo Chae. (2019). Clinical Effects of Hypomethylating Agents in Patients with Newly Diagnosed Myelodysplastic Syndrome Who Received DNA-Damaging Chemotherapy for Metastatic Breast Cancer. Journal of Breast Cancer. 22(4). 647–647. 1 indexed citations

Lee, Jeeyeon, Jin Hyang Jung, Wan Wook Kim, et al.. (2019). Absence of estrogen receptor is associated with worse oncologic outcome in patients who were received neoadjuvant chemotherapy for breast cancer. Asian Journal of Surgery. 43(3). 467–475. 6 indexed citations

Kim, Ji‐Yeon, Seri Park, Seock‐Ah Im, et al.. (2019). Quality of life outcomes including neuropathy‐associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first‐line chemotherapy for HER2‐negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13‐11). Cancer Communications. 39(1). 29–29. 3 indexed citations

Lee, Jeeyeon, Ho Yong Park, Wan Wook Kim, et al.. (2017). Biological function of long noncoding RNAsnaRin HER2-positive breast cancer cells. Tumor Biology. 39(6). 3726132337–3726132337. 25 indexed citations

10.

Moon, Pyong-Gon, Jeong‐Eun Lee, Young-Eun Cho, et al.. (2015). Identification of Developmental Endothelial Locus-1 on Circulating Extracellular Vesicles as a Novel Biomarker for Early Breast Cancer Detection. Clinical Cancer Research. 22(7). 1757–1766. 168 indexed citations

11.

Oh, Sung Yong, Won Seog Kim, Jin Seok Kim, et al.. (2015). A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial. Leukemia & lymphoma. 57(6). 1406–1412. 4 indexed citations

12.

Kang, Sun‐Hee, Yee Soo Chae, Soo Jung Lee, et al.. (2015). Aquaporin 3 Expression Predicts Survival in Patients with HER2-positive Early Breast Cancer.. PubMed. 35(5). 2775–82. 34 indexed citations

13.

Kang, Byung Woog, Jong Gwang Kim, Soo Jung Lee, et al.. (2015). Expression of Aquaporin-1, Aquaporin-3, and Aquaporin-5 Correlates with Nodal Metastasis in Colon Cancer. Oncology. 88(6). 369–376. 71 indexed citations

14.

Kang, Byung Woog, Sang Kyun Sohn, Joon Ho Moon, et al.. (2014). Clinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the Consortium for Improving Survival of Lymphoma. Blood Research. 49(1). 15–15. 15 indexed citations

15.

Lee, Soo Jung, Yee Soo Chae, Jong Gwang Kim, et al.. (2013). AQP5 Expression Predicts Survival in Patients with Early Breast Cancer. Annals of Surgical Oncology. 21(2). 375–383. 62 indexed citations

16.

Lee, Soo Jung, Byung Min Ahn, Jong Gwang Kim, et al.. (2009). Definitive Chemoradiotherapy with Capecitabine and Cisplatin in Patients with Esophageal Cancer: A Pilot Study. Journal of Korean Medical Science. 24(1). 120–120. 9 indexed citations

17.

Kwak, Jae‐Yong, Ho‐Young Yhim, Hye Jin Kang, et al.. (2009). Clinical Features and Treatment Outcomes of Non-Hodgkin's Lymphoma with Breast Involvement; Multi-Institutional Analysis of 98 Patients in Korea.. Blood. 114(22). 5024–5024.

18.

Cho, Yoon Young, Jong Gwang Kim, Yee Soo Chae, et al.. (2008). Salvage treatments with all-trans retinoic acid and arsenic trioxide-based regimens in acute promyelocytic leukemia. The Korean Journal of Internal Medicine. 74(6). 596–604. 2 indexed citations

19.

Kim, Jong Gwang, Sang Kyun Sohn, Yee Soo Chae, et al.. (2008). TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin. Cancer Chemotherapy and Pharmacology. 64(2). 355–360. 36 indexed citations

20.

Kim, Jong Gwang, Sang Kyun Sohn, Yee Soo Chae, et al.. (2005). CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas. Cancer Chemotherapy and Pharmacology. 58(1). 35–39. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact